The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000485336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
3/03/2026
Date registered
Help: Date registered
17/04/2026
Date last updated
Help: Date last updated
17/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Comparison of splint to cast for treatment of distal forearm fractures in children: a pilot feasibility randomised controlled trial
Scientific title
Clinical Assessment of Splint Therapy – Alternative Ways to treat Arm fractures in Youth
(CAST-AWAY): a pilot feasibility randomised controlled trial
Additional trial identifiers [1] 316671 0
None
Universal Trial Number (UTN)
U1111-1336-5099
Trial acronym
CAST-AWAY (Pilot RCT)
Related trial records

Health condition
Health condition(s) studied:
distal radius fracture 340916 0
Condition category
Condition code
Injuries and Accidents 337068 337068 0 0
Fractures

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Forearm splint. A prefabricated removable splint (any brand) made of contoured plastic with padding, elasticised fabric and velcro, that come in a range of sizes. This will be applied in the emergency department by the treating clinician and will be worn continuously throughout the day for 4-6 weeks, only removed for showering or hand hygiene. The treating clinician will administer the splint and then the family will manage it ongoing. Electronic surveys at 1, 4 and 8 weeks will capture the duration of immobilisation.
Intervention code [1] 333353 0
Treatment: Devices
Description of the comparator or control
Short-arm cast. Short-arm plaster of paris back slab cast placed in the emergency department by either a treating clinician or plaster technician. This will be replaced at around 1-2 weeks by a short-arm synthetic (or similar) circumferential cast in the orthopaedic fracture clinic by a plaster technician that is worn for up to a further 5 weeks (total of 4-6 weeks immobilisation).
Control group
Active

Outcomes
Primary outcome [1] 344583 0
Feasibility of recruitment
Timepoint [1] 344583 0
Assessed at the conclusion of study recruitment
Secondary outcome [1] 458469 0
Secondary recruitment feasibility outcome - Number of patients screened who were not eligible (and reasons for ineligibility)
Timepoint [1] 458469 0
Assessed at the conclusion of study recruitment
Secondary outcome [2] 458470 0
Secondary recruitment feasibility outcome - Number of eligible patients not screened (and reasons missed)
Timepoint [2] 458470 0
Assessed at the conclusion of study recruitment
Secondary outcome [3] 458471 0
Secondary recruitment feasibility outcome - Reasons eligible, screened patients not recruited (i.e. not approached or did not provided consent)
Timepoint [3] 458471 0
Assessed at the conclusion of study recruitment
Secondary outcome [4] 458472 0
Secondary recruitment feasibility outcome - Proportion of participants managed per trial protocol
Timepoint [4] 458472 0
Assessed at the conclusion of study recruitment
Secondary outcome [5] 458473 0
Secondary recruitment feasibility outcome - Proportion of participants with complete 8 week follow-up data
Timepoint [5] 458473 0
Assessed at the conclusion of study recruitment
Secondary outcome [6] 458474 0
Secondary clinical outcome - adverse events (i.e. safety)
Timepoint [6] 458474 0
1, 4 and 8 weeks post treatment administration
Secondary outcome [7] 458476 0
Secondary clinical outcome - recovery of arm function
Timepoint [7] 458476 0
Baseline, and 1, 4 and 8 weeks post treatment administration
Secondary outcome [8] 458478 0
Secondary clinical outcome - Pain
Timepoint [8] 458478 0
1, 4 and 8 weeks post treatment administration
Secondary outcome [9] 458487 0
Secondary clinical outcome - Participant (patient) satisfaction
Timepoint [9] 458487 0
1, 4 and 8 weeks post treatment administration
Secondary outcome [10] 458488 0
Secondary clinical outcome - Parent satisfaction
Timepoint [10] 458488 0
1, 4 and 8 weeks post treatment administration
Secondary outcome [11] 459264 0
Length of stay - Emergency department
Timepoint [11] 459264 0
Emergency department discharge
Secondary outcome [12] 459265 0
Length of stay - Treatment time in the Emergency Department
Timepoint [12] 459265 0
Emergency department discharge
Secondary outcome [13] 459266 0
Number of anticipated visits to medical practitioners (emergency department, orthopaedic fracture clinic, or general practitioner) after initial discharge from the emergency department
Timepoint [13] 459266 0
8 weeks post treatment administration
Secondary outcome [14] 459267 0
Number of unanticipated visits to the medical practitioners (emergency department, orthopaedic fracture clinic, or general practitioner) after initial discharge from the emergency department
Timepoint [14] 459267 0
8 weeks post treatment administration
Secondary outcome [15] 459268 0
Secondary clinical outcome - Direct costs to families
Timepoint [15] 459268 0
Evaluated at 8 weeks post treatment administered.
Secondary outcome [16] 459269 0
Secondary clinical outcome - Indirect costs to families
Timepoint [16] 459269 0
Evaluated at 8 weeks post treatment administered.
Secondary outcome [17] 459270 0
Secondary clinical outcome - days off school
Timepoint [17] 459270 0
8 weeks post treatment administration

Eligibility
Key inclusion criteria
Isolated, acute (<72hrs), clinically non-deformed, distal radius +/- ulna incomplete (angulation <10 degrees) fracture per treating clinician X-ray interpretation..
Minimum age
4 Years
Maximum age
15 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Soft tissue injuries (‘sprains’) or buckle fractures (buckling of the cortex but no cortical breach) of the distal forearm will be excluded, as the safety of minimal intervention for these groups has been established. Patients with complete, angulated >10 degrees or displaced fractures, fractures of the midshaft forearm, proximal forearm, or scaphoid (including suspected) will be excluded, as will patients with distal forearm fractures that are manipulated or have surgical intervention planned

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation conducted using an interactive web-based randomisation service
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
1:1 ratio in blocks of size 6-8
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Descriptive statistics will include means with standard deviations for normally distributed continuous variables, medians with interquartile ranges for non-normal distributions, and frequencies with percentages for categorical variables.

Primary Analysis
The primary outcome is the recruitment rate amongst screened, eligible patients. We will calculate the proportion recruited along with the Clopper-Pearson 95% confidence interval (CI).
Feasibility metrics will be summarised descriptively, with proportions and Clopper-Pearson 95% CIs reported for:
- Screening and eligibility rates by site and month
- Reasons for ineligibility, non-approach, and declining consent will be categorised and
reported as frequencies
- Protocol deviations will be classified by type and timing
- Follow-up completion rates
For clinical outcomes, between-group comparisons will use linear regression for continuous variables and logistic regression for binary outcomes. Regression models will include randomisation group as the main effect and stratification factors as covariables. As this is a pilot study, these analyses are exploratory and will inform outcome selection and sample size calculations for the definitive trial.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD,TAS

Funding & Sponsors
Funding source category [1] 321283 0
Charities/Societies/Foundations
Name [1] 321283 0
Emergency Medicine Foundation
Country [1] 321283 0
Australia
Primary sponsor type
Hospital
Name
Gold Coast University Hospital
Address
Country
Australia
Secondary sponsor category [1] 324004 0
None
Name [1] 324004 0
Address [1] 324004 0
Country [1] 324004 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319812 0
Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 319812 0
Ethics committee country [1] 319812 0
Australia
Date submitted for ethics approval [1] 319812 0
17/11/2025
Approval date [1] 319812 0
17/12/2025
Ethics approval number [1] 319812 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148486 0
A/Prof Peter J. Snelling
Address 148486 0
Gold Coast University Hospital, 1 Hospital Blvd, Southport, Qld, 4215
Country 148486 0
Australia
Phone 148486 0
+61 756875986
Fax 148486 0
Email 148486 0
Contact person for public queries
Name 148487 0
Peter J. Snelling
Address 148487 0
Gold Coast University Hospital, 1 Hospital Blvd, Southport, Qld, 4215
Country 148487 0
Australia
Phone 148487 0
+61 7 1300 744 284
Fax 148487 0
Email 148487 0
Contact person for scientific queries
Name 148488 0
Peter J. Snelling
Address 148488 0
Gold Coast University Hospital, 1 Hospital Blvd, Southport, Qld, 4215
Country 148488 0
Australia
Phone 148488 0
+61 7 1300 744 284
Fax 148488 0
Email 148488 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 5 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Contact with the principal investigator: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.